Literature DB >> 6161102

Intraocular effects of substance P in the rabbit.

J Stjernschantz, M Sears, L Stjernschantz.   

Abstract

The intraocular effects of substance P (SP) were studied in rabbits by measuring the pupil diameter, intraocular pressure (IOP), and aqueous humor protein concentration. Most of the animals were pretreated with indomethacin to avoid any interaction with prostaglandins. Intracameral injection of 1 to 150 ng of SP caused strong and persistent miosis without appreciably affecting the aqueous humor protein concentration or IOP. Intracameral injection of 0.8 to 11 micrograms of SP also induced an increase in IOP (7 to 8 mm Hg) without any apparent concomitant disruption in the blood-aqueous barrier. Outflow facility of aqueous humor decreased by a mean value of 50% after intracameral injection of 0.8 to 1.5 microgram of SP. Since the increase in IOP could be prevented by iridectomy, it was probably caused by a pupillary block from the intense miosis induced by SP. No disruption in the blood-aqueous barrier could be detected after intra-arterial infusion of 10 micrograms of SP or intravitreal injection of 100 ng of SP, indicating that the ciliary epithelium was practically insensitive to exogenous SP. Topical as well as subconjunctival administration of up to 1 mg of SP did not cause any irritative response in the eye. The results show that with concentrations of SP causing intense miosis, the eye does not exhibit visible hyperemia and disruption of the blood-aqueous barrier. This finding is consistent with the hypothesis that after certain irritative stimuli, miosis is mediated by a pathway separate from the hyperemia and disruption of the blood-aqueous barrier.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161102

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Immunohistochemical demonstration of neurotensin and tyrosine hydroxylase in iris nerves of the rabbit eye.

Authors:  D E Hernandez; L Jennes
Journal:  Histochemistry       Date:  1989

2.  Correlation of neuronal size and peptide immunoreactivity in the guinea-pig trigeminal ganglion.

Authors:  W Kummer; C Heym
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Substance P, neurokinin A and neurokinin B in the ocular response to injury in the rabbit.

Authors:  B Beding-Barnekow; E Brodin; R Håkanson
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 4.  Autonomic control of the eye.

Authors:  David H McDougal; Paul D Gamlin
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

5.  Substance P-like immunoreactive trigeminal ganglion cells supplying the cornea.

Authors:  J I Lehtosalo
Journal:  Histochemistry       Date:  1984

6.  Ocular responses evoked by capsaicin and prostaglandin E2 are inhibited by a substance P antagonist.

Authors:  G Bynke; R Håkanson; J Hörig
Journal:  Experientia       Date:  1983-09-15

7.  Mapping, quantitative distribution and origin of substance p- and VIP-containing nerves in the uvea of guinea pig eye.

Authors:  G Terenghi; J M Polak; L Probert; G P McGregor; G L Ferri; M A Blank; J M Butler; W G Unger; S Zhang; D F Cole; S R Bloom
Journal:  Histochemistry       Date:  1982

8.  Role of substance P in the antidromic vasodilation, neurogenic plasma extravasation and disruption of the blood-aqueous barrier in the rabbit eye.

Authors:  J Stjernschantz; M Sears; H Mishima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

9.  Substance P-immunoreactive nerve fibres in the anterior segment of the rabbit eye. Distribution and possible physiological significance.

Authors:  K Tornqvist; A Mandahl; S Leander; I Lorén; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

10.  Sympathectomy enhances the substance P-mediated breakdown of the blood-aqueous barrier in response to infrared irradiation of the rabbit iris.

Authors:  G Bynke; A Bruun; R Håkanson
Journal:  Experientia       Date:  1985-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.